Results 81 to 90 of about 5,055 (197)

DEVELOPMENT AND VALIDATION OF STABILITY-INDICATING HPTLC METHOD FOR THE ESTIMATION OF PERINDOPRIL AND INDAPAMIDE [PDF]

open access: yes, 2014
Objective: To develop a validated stability indicating HPTLC method for determination Perindopril and Indapamide. Methods: The method was based on the separation of two drugs on plates precoated with silica gel 60 F254 using Dichloromethane: Methanol ...
Hibare, Viraj   +2 more
core   +1 more source

Diuretic agents related to indapamide

open access: yes, 1989
A series of N-(4-chloro-3-sulfamoylbenzamido)-1,2,3,4-tetrahydroquinoline (IV-1) and isoquinoline (IV-2) have been synthesized and their diuretic and antihypertensive activities evaluated.
M. Miele   +6 more
core   +2 more sources

Menopausal metabolic syndrome after hysterectomy

open access: yesКардиоваскулярная терапия и профилактика, 2005
Aim. To study indapamide retard 1,5 mg effects in women with menopausal metabolic syndrome (MMS) after hysterectomy. Material and methods. The study involved 25 women (mean age 43.82±4.08 years), who underwent subtotal hysterectomy, with one or two ...
V. I. Podzolkov   +2 more
doaj  

Indapamide enhances the protective action of carbamazepine, phenobarbital, and valproate against maximal electroshock-induced seizures in mice [PDF]

open access: yes, 2020
Purpose: To determine the influence of indapamide on the protective action of numerous conventional and second-generation antiepileptic drugs (carbamazepine, lamotrigine, oxcarbazepine, phenobarbital, topiramate and valproate) in the mouse maximal ...

core  

The investigation of kinetics dissolution of prolonged indapamide drugs in biorelevant media

open access: yesСеченовский вестник, 2013
In the current work there was performed the development of the method of determination dissolution kinetics in biorelevant media of slightly soluble substance, for example indapamide. The method was validated in terms of specificity, linearity, precision,
E. Yu. Sannikova   +3 more
doaj  

Fixed combinations of perindopril and indapamide in hypertensive high-risk patients: antihypertensive efficacy

open access: yes, 2017
Objective.The aim of the study was to compare the antihypertensive efficacy of fixed combinations of perindopril and indapamide in patients with arterial hypertension (HTN) and high cardiovascular risk.Design and methods.We included 65 patients with 1–2 ...
M. V. Savchenko   +6 more
core   +1 more source

Early stages of hypertensive encephalopathy development and modern potential of cerebro-protective therapy

open access: yesКардиоваскулярная терапия и профилактика, 2008
Aim. To study structural cerebral changes in patients with arterial hypertension (AH), taking into consideration 24-hour blood pressure monitoring (BPM) results and their dynamics during antihypertensive therapy.Material and methods.
M. F. Mordovin   +2 more
doaj  

Single-pill combination of indapamide and perindopril: potential of practical application

open access: yesРоссийский кардиологический журнал
The effectiveness of blood pressure control can be increased with the use of single-pill combinations. When choosing an agent, the evidence of its components should be focused.
A. M. Kochergina, V. V. Kashtalap
doaj   +1 more source

Fixed Dose Combination of Perindopril and Indapamide Improves Peripheral Vascular Function in Essential Hypertensive Patients

open access: yes, 2009
BACKGROUND: The effect on endothelium-dependent and independent vasodilation of 24-week treatment with a fixed-dose combination of perindopril/indapamide (2/0.625 mg, daily) and atenolol (50 mg, daily), was evaluated in 62 untreated essential ...
GHIADONI, LORENZO   +4 more
core   +1 more source

Use of indapamide in hospital and community clinics and its effect on plasma potassium in Chinese patients

open access: yes, 1998
Objectives: To investigate the usage pattern of indapamide and other antihypertensive drugs in patients attending a community-based government outpatient clinic (GOPC) or a hospital-based specialist clinic (SC).
Chang, S   +8 more
core   +1 more source

Home - About - Disclaimer - Privacy